Arbutus Biopharma Corp·4

Feb 17, 5:00 PM ET

Collier William H. 4

4 · Arbutus Biopharma Corp · Filed Feb 17, 2021

Insider Transaction Report

Form 4
Period: 2021-02-13
Collier William H.
DirectorPresident and CEO
Transactions
  • Award

    Stock Options

    2021-02-13+675,000675,000 total
    Exercise: $4.33Exp: 2031-02-13Common Stock (675,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest and become exercisable 1/48th each month over the four year period.

Documents

2 files
  • 4
    wf-form4_161359921500159.xmlPrimary

    FORM 4

  • EX-24

    POA - COLLIER